Noile-Immune Biotech Inc. (4893.T)

JPY 166.0

(-1.78%)

Operating Expenses Summary of Noile-Immune Biotech Inc.

  • Noile-Immune Biotech Inc.'s latest annual operating expenses in 2023 was 1.08 Billion JPY , up 50.33% from previous year.
  • Noile-Immune Biotech Inc.'s latest quarterly operating expenses in 2024 Q2 was 342.53 Million JPY , up 0.25% from previous quarter.
  • Noile-Immune Biotech Inc. reported a annual operating expenses of 725.05 Million JPY in annual operating expenses 2022, down -14.23% from previous year.
  • Noile-Immune Biotech Inc. reported a annual operating expenses of 845.34 Million JPY in annual operating expenses 2021, up 20.97% from previous year.
  • Noile-Immune Biotech Inc. reported a quarterly operating expenses of 342.53 Million JPY for 2024 Q2, up 0.25% from previous quarter.
  • Noile-Immune Biotech Inc. reported a quarterly operating expenses of 282.04 Million JPY for 2023 Q4, down -11.0% from previous quarter.

Annual Operating Expenses Chart of Noile-Immune Biotech Inc. (2023 - 2020)

Historical Annual Operating Expenses of Noile-Immune Biotech Inc. (2023 - 2020)

Year Operating Expenses Operating Expenses Growth
2023 1.08 Billion JPY 50.33%
2022 725.05 Million JPY -14.23%
2021 845.34 Million JPY 20.97%
2020 698.78 Million JPY 0.0%

Peer Operating Expenses Comparison of Noile-Immune Biotech Inc.

Name Operating Expenses Operating Expenses Difference
KOHJIN BIO CO LTD 1.28 Billion JPY 15.144%
PRISM BioLab Co.,LTD 576.81 Million JPY -88.96%
GNI Group Ltd. 9.32 Billion JPY 88.308%
Linical Co., Ltd. 2.7 Billion JPY 59.709%
Trans Genic Inc. 2.15 Billion JPY 49.535%
MEDINET Co., Ltd. 1.49 Billion JPY 26.906%
Soiken Holdings Inc. 3.07 Billion JPY 64.509%
Cytori Cell Research Institute, Inc. 1.85 Billion JPY 41.305%
AnGes, Inc. 8.9 Billion JPY 87.756%
OncoTherapy Science, Inc. 943.08 Million JPY -15.574%
Nxera Pharma Co., Ltd. 19.19 Billion JPY 94.32%
Immuno-Biological Laboratories Co., Ltd. 412.99 Million JPY -163.917%
NanoCarrier Co., Ltd. 975.37 Million JPY -11.747%
Carna Biosciences, Inc. 2.56 Billion JPY 57.549%
CanBas Co., Ltd. 278 Million JPY -292.069%
D. Western Therapeutics Institute, Inc. 1.14 Billion JPY 4.519%
RaQualia Pharma Inc. 1.81 Billion JPY 40.045%
Chiome Bioscience Inc. 1.6 Billion JPY 32.038%
Kidswell Bio Corporation 2.37 Billion JPY 54.089%
PeptiDream Inc. 9.68 Billion JPY 88.749%
Oncolys BioPharma Inc. 1.96 Billion JPY 44.407%
Ribomic Inc. 1.1 Billion JPY 1.423%
SanBio Company Limited 4.53 Billion JPY 75.987%
Healios K.K. 3.48 Billion JPY 68.742%
BrightPath Biotherapeutics Co., Ltd. 1.15 Billion JPY 5.61%
Kubota Pharmaceutical Holdings Co., Ltd. 1.33 Billion JPY 18.323%
Delta-Fly Pharma, Inc. 1.4 Billion JPY 22.338%
StemRIM 2.07 Billion JPY 47.497%
CellSource Co., Ltd. 1.96 Billion JPY 44.489%
FunPep Company Limited 313.82 Million JPY -247.316%
Kringle Pharma, Inc. 958.01 Million JPY -13.772%
Stella Pharma Corporation 963.98 Million JPY -13.067%
TMS Co., Ltd. 943.25 Million JPY -15.552%
Cuorips Inc. 598.11 Million JPY -82.23%
K Pharma,Inc. 543.94 Million JPY -100.38%
Takara Bio Inc. 23.9 Billion JPY 95.44%
ReproCELL Incorporated 1.51 Billion JPY 28.009%
PhoenixBio Co., Ltd. 1.18 Billion JPY 7.942%
StemCell Institute Inc. 1.16 Billion JPY 6.21%
Japan Tissue Engineering Co., Ltd. 1.52 Billion JPY 28.4%
CellSeed Inc. 804.93 Million JPY -35.409%